Collaboration Details

Print  Close

Title of Collaborative Activity:

Consortium for Tuberculosis (TB) Biomarkers (CTB2)

Description of Collaborative Activity:

The Consortium seeks to establish a robust biorepository of well-documented clinical specimens to support the discovery and qualification of biomarkers of Tuberculosis (TB) drug effect, especially surrogate markers for stable cure vs. relapse, and to facilitate development of rapid, reliable TB diagnostics, including tests for drug-susceptibility that would be practical for use in resource poor settings. .

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: